The balance sheet is structurally dominated by goodwill from acquisitions, with intangible assets comprising 59% of total assets ($716.5M out of $1.2B), while leverage spiked with a D/E ratio of 0.46 in Q1 2026 before a recent partial reduction to 0.22 in Q2 2026 following a major debt repayment.
U.S. Physical Therapy, Inc. (USPH) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 139.68M | 139.99M | 137.58M | 233.38M | 111.27M | 95.17M | 87.64M | 85.39M | 79.21M | 77.08M | 65.96M | 60.18M | 54.85M | 49.66M | 45.32M | 45.67M | 39.28M | 32.84M | 38.72M | 36.03M | 35.98M | 36.85M | 40.61M | 33.02M | 23.08M | 22.41M | 13.74M | 14.65M | 15.6M | 14M | 11.8M |
| Cash & Short-Term Investments | 24.89M | 35.57M | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.9M | 11.67M | 9.98M | 9.18M | 6.43M | 10.11M | 7.98M | 11.45M | 15M | 20.55M | 16.82M | 7.61M | 8.12M | 2.07M | 4.03M | 6.3M | 5.6M | 4.9M |
| Cash Only | 24.89M | 35.57M | 41.36M | 152.82M | 31.59M | 28.57M | 32.92M | 23.55M | 23.37M | 21.93M | 20.05M | 15.78M | 14.27M | 12.9M | 11.67M | 9.98M | 9.18M | 6.43M | 10.11M | 7.98M | 10.95M | 15M | 20.55M | 16.82M | 7.61M | 8.12M | 2.07M | 4.03M | 6.3M | 5.6M | 4.9M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 69.6M | 88.34M | 85.67M | 69.72M | 69.31M | 62.42M | 50.95M | 56.05M | 51.49M | 50.36M | 41.49M | 38.62M | 34.59M | 32.66M | 27.68M | 29.95M | 26.37M | 23.63M | 26.75M | 26.72M | 22.28M | 20.42M | 18.22M | 14.4M | 13.68M | 13.65M | 11.15M | 9.99M | 8.7M | 7.9M | 6.5M |
| Days Sales Outstanding | 44.82 | 41.28 | 46.58 | 42.08 | 45.73 | 46.02 | 43.96 | 42.45 | 41.41 | 44.4 | 42.47 | 42.55 | 41.39 | 45.15 | 40.07 | 46.12 | 45.56 | 42.82 | 52.02 | 64.31 | 60.15 | 56.42 | 56.21 | 49.79 | 52.7 | 61.54 | 64.39 | 73.01 | 72.17 | 74.32 | 73.68 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 45.19M | 16.08M | 10.55M | 10.83M | 10.37M | 4.18M | 3.77M | 5.79M | 11.1M | 10.44M | 7.08M | 8.19M | 7.69M | 5.94M | 7.68M | 7.35M | 3.74M | 2.96M | 1.86M | 1.33M | 2.25M | 1.43M | 1.83M | 1.8M | 1.79M | 646K | 519K | 630K | 600K | 500K | 400K |
| Total Non-Current Assets | 1.11B | 1.06B | 1.03B | 763.86M | 746.89M | 654.26M | 506.73M | 475.46M | 363.95M | 341.9M | 285.27M | 219.73M | 189.7M | 174.47M | 126.39M | 117.58M | 101.58M | 78.41M | 79.53M | 60.22M | 35.48M | 29.67M | 21M | 19.45M | 17.95M | 13.77M | 9.23M | 8.7M | 8.5M | 8.5M | 7.7M |
| Property, Plant & Equipment | 291M | 271.07M | 166.08M | 129.53M | 127.75M | 119.41M | 103.26M | 103.68M | 20.17M | 20.39M | 19.17M | 16.65M | 15.76M | 14.96M | 13.02M | 13.19M | 13.92M | 14.34M | 15.84M | 16.79M | 13.37M | 13.74M | 13.65M | 11.81M | 10.41M | 7.8M | 6.99M | 6.49M | 6.4M | 6M | 6M |
| Fixed Asset Turnover | 3.05x | 2.88x | 4.04x | 4.67x | 4.33x | 4.15x | 4.10x | 4.65x | 22.51x | 20.31x | 18.60x | 19.89x | 19.35x | 17.65x | 19.37x | 17.97x | 15.17x | 14.05x | 11.85x | 9.03x | 10.11x | 9.62x | 8.67x | 8.94x | 9.10x | 10.37x | 9.04x | 7.70x | 6.88x | 6.47x | 5.37x |
| Goodwill | 716.53M | 692.39M | 667.15M | 509.57M | 494.1M | 434.68M | 345.65M | 317.68M | 293.52M | 271.34M | 226.81M | 171.55M | 147.91M | 143.96M | 100.19M | 92.75M | 79.42M | 57.25M | 55.89M | 37.65M | 21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 176.55M | 172.86M | 179.31M | 109.68M | 108.75M | 86.38M | 56.28M | 52.59M | 48.83M | 48.95M | 38.06M | 30.3M | 24.91M | 14.48M | 12.15M | 9.6M | 7.31M | 5.96M | 6.45M | 3.93M | 0 | 14.34M | 6.13M | 5.68M | 5.59M | 4.52M | 897K | 948K | 1M | 1.2M | 800K |
| Long-Term Investments | 37.01M | 12.28M | 12.19M | 12.26M | 12.13M | 12.21M | 0 | 0 | -2.48M | -2.06M | -2.54M | -2.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -74.88M | -84.58M | 5.16M | 2.82M | 4.15M | 1.58M | 1.54M | 1.52M | 1.43M | 1.22M | 1.23M | 1.23M | 1.11M | 1.08M | 1.04M | 2.04M | 922K | 869K | 1.35M | 1.85M | 1.11M | 1.59M | 1.23M | 1.96M | 1.95M | 1.45M | 1.34M | 1.26M | 1.1M | 1.3M | 900K |
| Total Assets | 1.25B | 1.2B | 1.17B | 997.24M | 858.15M | 749.43M | 594.36M | 560.85M | 443.17M | 418.98M | 351.23M | 279.91M | 244.55M | 224.13M | 171.71M | 163.25M | 140.86M | 111.25M | 118.25M | 96.25M | 71.46M | 66.52M | 61.61M | 52.47M | 41.03M | 36.18M | 22.97M | 23.35M | 24.1M | 22.5M | 19.5M |
| Asset Turnover | 0.58x | 0.65x | 0.58x | 0.61x | 0.64x | 0.66x | 0.71x | 0.86x | 1.02x | 0.99x | 1.02x | 1.18x | 1.25x | 1.18x | 1.47x | 1.45x | 1.50x | 1.81x | 1.59x | 1.58x | 1.89x | 1.99x | 1.92x | 2.01x | 2.31x | 2.24x | 2.75x | 2.14x | 1.83x | 1.72x | 1.65x |
| Asset Growth % | 30.52% | 3.13% | 17.07% | 16.21% | 14.51% | 26.09% | 5.98% | 26.55% | 5.77% | 19.29% | 25.48% | 14.46% | 9.11% | 30.53% | 5.18% | 15.9% | 26.61% | -5.91% | 22.85% | 34.7% | 7.42% | 7.97% | 17.41% | 27.88% | 13.4% | 57.53% | -1.61% | -3.13% | 7.11% | 15.38% | 22.64% |
| Total Current Liabilities | 109.91M | 139.04M | 116.28M | 102.19M | 85.49M | 83.48M | 93.49M | 60.56M | 41.95M | 39.55M | 24.62M | 19.01M | 25.5M | 23.17M | 16.31M | 16.32M | 14.23M | 14.59M | 14.61M | 11.44M | 9.17M | 7.12M | 5.62M | 5.42M | 2.85M | 3.25M | 3.32M | 2.16M | 2.6M | 2.8M | 2.6M |
| Accounts Payable | 6.92M | 6.06M | 5.94M | 3.9M | 6.5M | 6.47M | 1.33M | 2.49M | 2.02M | 2.17M | 1.63M | 1.64M | 1.78M | 1.72M | 1.73M | 1.81M | 1.24M | 1.29M | 1.48M | 1.55M | 1.6M | 1.72M | 1.18M | 498K | 624K | 539K | 434K | 349K | 600K | 300K | 300K |
| Days Payables Outstanding | 4.5 | 3.55 | 3.96 | 2.94 | 5.38 | 6.25 | 1.48 | 2.46 | 2.09 | 2.44 | 2.17 | 2.36 | 2.84 | 3.15 | 3.34 | 3.83 | 2.97 | 3.22 | 3.86 | 4.96 | 5.88 | 6.53 | 5.05 | 2.44 | 3.53 | 3.58 | 3.69 | 3.74 | 7.11 | 4.01 | 4.95 |
| Short-Term Debt | 47.43M | 52M | 11M | 7.69M | 7.86M | 830K | 4.9M | 728K | 1.43M | 4.04M | 1.23M | 775K | 883K | 825K | 459K | 433K | 250K | 1.01M | 1.38M | 812K | 562K | 244K | 70K | 2.37M | 4K | 701K | 912K | 39K | 0 | 100K | 100K |
| Deferred Revenue (Current) | 1.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -175K | 0 | 0 | 0 | 0 | 0 | 0 | 2.19M | 1.9M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 62.48M | 80.98M | 0 | 22.49M | 0 | 0 | 0 | 0 | 16.77M | 9.52M | 11.19M | 5.71M | 5.61M | 6.57M | 2.85M | 4.01M | 3.75M | 3.33M | 5.25M | 4.17M | 4.76M | 3.01M | 0 | 0 | 33K | -445K | 1.98M | 1.77M | 2M | 2.4M | 2.2M |
| Current Ratio | 1.27x | 1.01x | 1.18x | 2.28x | 1.30x | 1.14x | 0.94x | 1.41x | 1.89x | 1.95x | 2.68x | 3.17x | 2.15x | 2.14x | 2.78x | 2.80x | 2.76x | 2.25x | 2.65x | 3.15x | 3.92x | 5.18x | 7.23x | 6.09x | 8.10x | 6.90x | 4.14x | 6.79x | 6.00x | 5.00x | 4.54x |
| Quick Ratio | 1.27x | 1.01x | 1.18x | 2.28x | 1.30x | 1.14x | 0.94x | 1.41x | 1.89x | 1.95x | 2.68x | 3.17x | 2.15x | 2.14x | 2.78x | 2.80x | 2.76x | 2.25x | 2.65x | 3.15x | 3.92x | 5.18x | 7.23x | 6.09x | 8.10x | 6.90x | 4.14x | 6.79x | 6.00x | 5.00x | 4.54x |
| Cash Conversion Cycle | 40.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 372.31M | 294.77M | 292.14M | 242.81M | 288.1M | 213.5M | 90.9M | 120.83M | 50.4M | 70.46M | 68.74M | 58.95M | 44.46M | 45.84M | 20.75M | 25.35M | 10.25M | 4.44M | 15.81M | 9.76M | 2.9M | 2.9M | 2.5M | 429K | 2.62M | 3.02M | 7.23M | 8.09M | 8.2M | 8.1M | 8.3M |
| Long-Term Debt | 123.79M | 263.17M | 142.53M | 138.99M | 175.83M | 117.59M | 16.6M | 50.36M | 38.4M | 56.73M | 50.6M | 48.34M | 34.73M | 40.65M | 17.57M | 23.78M | 5.75M | 400K | 12.41M | 7.96M | 797K | 483K | 0 | 83K | 2.35M | 3.02M | 7.23M | 8.09M | 8.1M | 8.2M | 8.3M |
| Capital Lease Obligations | 331.96M | 110.57M | 101.87M | 76.65M | 77.93M | 74.19M | 61.98M | 60.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 94.86M | 28.39M | 29.46M | 24.82M | 21.3M | 14.38M | 7.78M | 10.07M | 9.01M | 10.88M | 15.74M | 9.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 248.52M | -107.36M | 18.27M | 2.36M | 13.03M | 7.34M | 4.54M | 141K | 12M | 13.73M | 18.14M | 1.4M | 9.72M | 5.19M | 3.17M | 623K | 3.53M | 3.01M | 3.4M | 1.8M | 2.1M | 2.42M | 2.5M | 346K | 273K | 0 | 0 | 0 | 100K | -100K | 0 |
| Total Liabilities | 482.22M | 433.81M | 408.42M | 345M | 373.59M | 296.98M | 184.39M | 181.39M | 92.35M | 110.01M | 93.35M | 77.96M | 69.96M | 69.01M | 37.05M | 41.67M | 24.48M | 19.03M | 30.43M | 21.2M | 12.07M | 10.02M | 8.12M | 5.85M | 5.47M | 6.27M | 10.55M | 10.24M | 10.8M | 10.9M | 10.9M |
| Total Debt | 171.22M | 425.74M | 295.23M | 258.59M | 295.34M | 223.08M | 110.99M | 137.83M | 39.84M | 60.77M | 51.82M | 49.11M | 35.62M | 41.48M | 18.03M | 24.22M | 6M | 1.41M | 13.79M | 8.77M | 1.36M | 727K | 70K | 2.46M | 2.35M | 3.72M | 8.14M | 8.13M | 8.1M | 8.3M | 8.4M |
| Net Debt | 146.34M | 390.17M | 253.87M | 105.76M | 263.74M | 194.51M | 78.07M | 114.28M | 16.47M | 38.84M | 31.78M | 33.33M | 21.35M | 28.58M | 6.36M | 14.23M | -3.18M | -5.02M | 3.68M | 795K | -9.59M | -14.28M | -20.48M | -14.37M | -5.26M | -4.4M | 6.07M | 4.1M | 1.8M | 2.7M | 3.5M |
| Debt / Equity | 0.22x | 0.55x | 0.39x | 0.40x | 0.61x | 0.49x | 0.27x | 0.36x | 0.11x | 0.20x | 0.20x | 0.24x | 0.20x | 0.27x | 0.13x | 0.20x | 0.05x | 0.02x | 0.16x | 0.12x | 0.02x | 0.01x | 0.00x | 0.05x | 0.07x | 0.12x | 0.66x | 0.62x | 0.61x | 0.72x | 0.98x |
| Debt / EBITDA | 1.61x | 4.14x | 3.61x | 3.82x | 4.13x | 2.71x | 1.76x | 1.78x | 0.57x | 0.94x | 0.89x | 0.89x | 0.68x | 0.94x | 0.42x | 0.59x | 0.15x | 0.04x | 0.46x | 0.35x | 0.06x | 0.03x | 0.00x | 0.12x | 0.11x | 0.19x | 0.64x | 0.87x | 1.07x | 1.24x | 1.58x |
| Net Debt / EBITDA | 1.38x | 3.79x | 3.10x | 1.56x | 3.69x | 2.37x | 1.24x | 1.47x | 0.24x | 0.60x | 0.54x | 0.60x | 0.41x | 0.64x | 0.15x | 0.34x | -0.08x | -0.15x | 0.12x | 0.03x | -0.42x | -0.62x | -1.01x | -0.70x | -0.24x | -0.23x | 0.48x | 0.44x | 0.24x | 0.40x | 0.66x |
| Interest Coverage | -44.90x | 9.23x | 8.51x | 6.31x | 10.62x | 78.70x | 41.09x | 35.11x | 30.49x | 2.60x | 4.32x | 6.54x | 6.14x | 72.08x | 68.96x | 74.34x | 143.12x | 80.28x | 44.53x | 66.56x | - | - | - | 89.64x | 87.79x | 63.71x | 13.31x | 9.99x | 7.86x | - | 5.14x |
| Total Equity | 766.15M | 769.74M | 759.05M | 652.24M | 484.57M | 452.44M | 409.97M | 379.45M | 350.82M | 308.97M | 257.88M | 201.95M | 174.59M | 155.12M | 134.66M | 121.58M | 116.38M | 92.22M | 87.82M | 75.06M | 59.39M | 56.5M | 53.49M | 46.63M | 35.56M | 29.91M | 12.42M | 13.1M | 13.3M | 11.6M | 8.6M |
| Equity Growth % | 21.28% | 1.41% | 16.38% | 34.6% | 7.1% | 10.36% | 8.04% | 8.16% | 13.54% | 19.81% | 27.69% | 15.67% | 12.55% | 15.2% | 10.76% | 4.47% | 26.19% | 5.01% | 17.01% | 26.38% | 5.11% | 5.63% | 14.72% | 31.11% | 18.87% | 140.84% | -5.2% | -1.48% | 14.66% | 34.88% | 45.76% |
| Book Value per Share | 50.68 | 50.72 | 50.39 | 45.97 | 37.32 | 35.08 | 31.94 | 29.75 | 27.70 | 24.58 | 20.63 | 16.30 | 14.29 | 12.84 | 11.31 | 10.15 | 9.80 | 7.81 | 7.29 | 6.41 | 5.08 | 4.69 | 4.33 | 3.88 | 2.81 | 2.33 | 1.16 | 1.33 | 1.23 | 1.07 | 0.81 |
| Total Shareholders' Equity | 448.66M | 476.43M | 488.93M | 476.19M | 315.79M | 295.61M | 276.16M | 240.26M | 215.94M | 204.87M | 187.55M | 162.78M | 146.28M | 128.29M | 117.32M | 107.05M | 103.96M | 87.35M | 81.61M | 69.41M | 55.52M | 53.48M | 50.18M | 43.35M | 32.54M | 26.67M | 9.56M | 10.72M | 11.6M | 10M | 7.6M |
| Common Stock | 175K | 174K | 172K | 172K | 152K | 151K | 151K | 150K | 149K | 148K | 147K | 146K | 145K | 143K | 141K | 139K | 139K | 138K | 142K | 141K | 137K | 136K | 134K | 122K | 118K | 107K | 57K | 36K | 0 | 0 | 0 |
| Retained Earnings | 213.36M | 227.22M | 227.26M | 223.77M | 232.95M | 224.4M | 212.01M | 184.35M | 167.4M | 162.41M | 150.34M | 149.02M | 134.19M | 119.21M | 111.32M | 102.41M | 89.88M | 81.21M | 69.45M | 59.44M | 50.7M | 44.41M | 35.62M | 28.94M | 21.61M | 13.12M | 6.05M | 2.31M | -100K | -1.7M | -4.1M |
| Treasury Stock | 0 | -37.19M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -26.11M | -18.11M | -12.52M | -12.5M | -1.99M | -47K | -47K | 0 | 0 | 0 |
| Accumulated OCI | 0 | 714K | 2.8M | 2.78M | 4M | 0 | 0 | 0 | -64.15M | -60.48M | -56.02M | -53.26M | -49.05M | 0 | -44.16M | -42.3M | -39.23M | -36.65M | -33.17M | -29.34M | -25.57M | -23.82M | -23.04M | -19.55M | -16.69M | -13.8M | -11.46M | -3.45M | -7.6M | -6M | -4.3M |
| Minority Interest | 317.49M | 293.31M | 270.12M | 176.04M | 168.78M | 156.84M | 133.81M | 139.19M | 134.87M | 104.1M | 70.33M | 39.17M | 28.31M | 26.83M | 17.34M | 14.53M | 12.43M | 4.87M | 6.21M | 5.65M | 3.87M | 3.02M | 3.31M | 3.28M | 3.02M | 3.25M | 2.86M | 2.38M | 1.7M | 1.6M | 1M |
Quick answers to the most common questions about buying USPH stock.
As of 2025, U.S. Physical Therapy, Inc. (USPH) had total assets of $1.20B including $140.0M in current assets.
U.S. Physical Therapy, Inc. (USPH) carries total debt of $425.7M, offset by $35.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
U.S. Physical Therapy, Inc. (USPH) has total shareholders' equity (book value) of $476.4M ($50.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.
U.S. Physical Therapy, Inc. (USPH) reported a current ratio of 1.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill concentration and cash erosion
Metrics are mathematically derived from official filings.
Leverage Expansion Erodes Equity Base
The balance sheet trajectory shows a notable weakening, with total liabilities growing 40% since 2024Q1 while equity has contracted, driving the D/E ratio from 0.38 to 0.46 by Q1 2026 before a recent partial deleveraging.
The sharp increase in total liabilities from $345.3M in 2024Q1 to $482.2M in 2026Q2 appears driven primarily by debt expansion, which suggests the company's growth strategy is increasingly reliant on external financing rather than retained earnings. This trend is coupled with a decline in retained earnings from a peak of $237.3M in 2025Q3 to $213.4M most recently, indicating that shareholder returns or operating losses are eroding the equity buffer. Investors should monitor whether this leverage increase is funding productive acquisitions or masking underlying operational weakness, especially given the concurrent margin pressure noted in the income statement.
Debt Reduction Follows Aggressive Accumulation
U.S. Physical Therapy's total debt has been volatile, peaking at $425.7M in Q4 2025 before a significant reduction to $171.2M by Q2 2026, suggesting an active and large-scale refinancing or repayment event has recently occurred.
The dramatic shift in debt levels from $362.8M to $171.2M in a single quarter is a material deleveraging event that has improved the D/E ratio from 0.46 to 0.22. This action appears strategic, potentially capitalizing on a strong cash flow quarter or an equity raise, though the cash balance declined modestly, which may indicate the repayment was funded by operating cash flow or asset sales rather than a pure cash windfall. The current debt level is below the 10-quarter average, but the prior volatility indicates a balance sheet that can shift rapidly, warranting investigation into the specific instrument repaid and its terms.
Goodwill Dominance Heightens Impairment Risk
Goodwill and intangible assets constitute a staggering 59% of total assets ($716.5M out of $1.2B), while tangible assets like PPE represent a much smaller fraction, highlighting the company's acquisition-driven growth model.
The asset mix is heavily skewed towards goodwill, which has grown steadily from $534.3M to $716.5M over the period, directly reflecting the company's acquisition strategy. This concentration means the balance sheet's strength is largely contingent on the success of past acquisitions and the performance of acquired clinic networks. Any impairment of this goodwill would severely impact reported equity and could trigger covenant issues, making the quality and cash flow generation of these acquired assets a critical, though opaque, focus for investors.
Diminished Cash Buffer Increases Near-Term Risk
Cash reserves have plummeted by 81% from a peak of $132.3M in Q1 2024 to just $24.9M in Q2 2026, drastically reducing the company's liquidity cushion against operational or financing shocks.
The decline in cash from $132.3M to $24.9M over ten quarters, concurrent with a drop in the current ratio from 2.16 to 1.27, signals a significant tightening of the liquidity position. This erosion appears driven by the combination of aggressive capital deployment for acquisitions and shareholder returns, as noted in cash flow analysis, against a backdrop of volatile operating cash flows. While the current ratio remains above 1.0, the minimal cash on hand leaves the company with a narrow margin for error and likely increases its dependence on revolver facilities or future financing for operational needs.
Acquisition-Fueled Model Masks Organic Weakness
The balance sheet is structurally dominated by goodwill from acquisitions, which may be obscuring a more concerning trend of declining organic equity growth and shrinking tangible book value.
Stripping out goodwill, tangible assets are only $483.5M against $482.2M in total liabilities, resulting in a near-zero tangible net worth. This suggests that the company's reported equity of $448.7M is almost entirely a function of acquisition accounting. Combined with the falling retained earnings and volatile profitability, this raises a key question: is the business generating sufficient organic earnings to sustain its goodwill-laden balance sheet, or is it reliant on a continuous cycle of debt-funded acquisitions to maintain its reported growth and equity base? This structural vulnerability could be exacerbated by any downturn in the elective physical therapy market or tightening of insurance reimbursement rates.